Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Supply, Demand and Key Producers, 2023-2029
The global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine total production and demand, 2018-2029, (K Units)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine total production value, 2018-2029, (USD Million)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine domestic production, consumption, key domestic manufacturers and share
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Kangtai and Walvax Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market, By Region:
1. How big is the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market?
2. What is the demand of the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market?
3. What is the year over year growth of the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market?
4. What is the production and production value of the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market?
5. Who are the key producers in the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market?
This report studies the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine total production and demand, 2018-2029, (K Units)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine total production value, 2018-2029, (USD Million)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine domestic production, consumption, key domestic manufacturers and share
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Kangtai and Walvax Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Vials
- Pre-filled
- Hospital
- Clinic
- CDC
- Pfizer
- Kangtai
- Walvax Biotechnology
1. How big is the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market?
2. What is the demand of the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market?
3. What is the year over year growth of the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market?
4. What is the production and production value of the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market?
5. Who are the key producers in the global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine market?
1 SUPPLY SUMMARY
1.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Introduction
1.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Supply & Forecast
1.2.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029)
1.2.3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Pricing Trends (2018-2029)
1.3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Region (Based on Production Site)
1.3.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Region (2018-2029)
1.3.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Region (2018-2029)
1.3.3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Region (2018-2029)
1.3.4 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029)
1.3.5 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029)
1.3.6 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029)
1.3.7 Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Demand (2018-2029)
2.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption by Region
2.2.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption by Region (2018-2023)
2.2.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029)
2.4 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029)
2.5 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029)
2.6 Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029)
2.7 South Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029)
2.8 ASEAN 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029)
2.9 India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029)
3 WORLD 13-VALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Manufacturer (2018-2023)
3.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Manufacturer (2018-2023)
3.3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Manufacturer (2018-2023)
3.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine in 2022
3.6 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market: Overall Company Footprint Analysis
3.6.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market: Region Footprint
3.6.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market: Company Product Type Footprint
3.6.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Comparison
4.1.1 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Comparison
4.2.1 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption Comparison
4.3.1 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2023)
4.5 China Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers and Market Share
4.5.1 China Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2023)
4.6 Rest of World Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Vials
5.2.2 Pre-filled
5.3 Market Segment by Type
5.3.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Type (2018-2029)
5.3.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Type (2018-2029)
5.3.3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 CDC
6.3 Market Segment by Application
6.3.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Application (2018-2029)
6.3.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Application (2018-2029)
6.3.3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product and Services
7.1.4 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Kangtai
7.2.1 Kangtai Details
7.2.2 Kangtai Major Business
7.2.3 Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product and Services
7.2.4 Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Kangtai Recent Developments/Updates
7.2.6 Kangtai Competitive Strengths & Weaknesses
7.3 Walvax Biotechnology
7.3.1 Walvax Biotechnology Details
7.3.2 Walvax Biotechnology Major Business
7.3.3 Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product and Services
7.3.4 Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Walvax Biotechnology Recent Developments/Updates
7.3.6 Walvax Biotechnology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Industry Chain
8.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Upstream Analysis
8.2.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Core Raw Materials
8.2.2 Main Manufacturers of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Mode
8.6 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Procurement Model
8.7 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Industry Sales Model and Sales Channels
8.7.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Model
8.7.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Introduction
1.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Supply & Forecast
1.2.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029)
1.2.3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Pricing Trends (2018-2029)
1.3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Region (Based on Production Site)
1.3.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Region (2018-2029)
1.3.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Region (2018-2029)
1.3.3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Region (2018-2029)
1.3.4 North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029)
1.3.5 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029)
1.3.6 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029)
1.3.7 Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Major Market Trends
2 DEMAND SUMMARY
2.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Demand (2018-2029)
2.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption by Region
2.2.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption by Region (2018-2023)
2.2.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029)
2.4 China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029)
2.5 Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029)
2.6 Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029)
2.7 South Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029)
2.8 ASEAN 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029)
2.9 India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029)
3 WORLD 13-VALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Manufacturer (2018-2023)
3.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Manufacturer (2018-2023)
3.3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Manufacturer (2018-2023)
3.4 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine in 2022
3.6 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market: Overall Company Footprint Analysis
3.6.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market: Region Footprint
3.6.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market: Company Product Type Footprint
3.6.3 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Comparison
4.1.1 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Comparison
4.2.1 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption Comparison
4.3.1 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2023)
4.5 China Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers and Market Share
4.5.1 China Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2023)
4.6 Rest of World Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Vials
5.2.2 Pre-filled
5.3 Market Segment by Type
5.3.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Type (2018-2029)
5.3.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Type (2018-2029)
5.3.3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 CDC
6.3 Market Segment by Application
6.3.1 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Application (2018-2029)
6.3.2 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Application (2018-2029)
6.3.3 World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product and Services
7.1.4 Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Kangtai
7.2.1 Kangtai Details
7.2.2 Kangtai Major Business
7.2.3 Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product and Services
7.2.4 Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Kangtai Recent Developments/Updates
7.2.6 Kangtai Competitive Strengths & Weaknesses
7.3 Walvax Biotechnology
7.3.1 Walvax Biotechnology Details
7.3.2 Walvax Biotechnology Major Business
7.3.3 Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product and Services
7.3.4 Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Walvax Biotechnology Recent Developments/Updates
7.3.6 Walvax Biotechnology Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Industry Chain
8.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Upstream Analysis
8.2.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Core Raw Materials
8.2.2 Main Manufacturers of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Mode
8.6 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Procurement Model
8.7 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Industry Sales Model and Sales Channels
8.7.1 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Model
8.7.2 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share by Region (2018-2023)
Table 9. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share by Region (2024-2029)
Table 10. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Major Market Trends
Table 13. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Producers in 2022
Table 18. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Producers in 2022
Table 20. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Company Evaluation Quadrant
Table 22. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Site of Key Manufacturer
Table 24. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market: Company Product Type Footprint
Table 25. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market: Company Product Application Footprint
Table 26. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Competitive Factors
Table 27. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine New Entrant and Capacity Expansion Plans
Table 28. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share (2018-2023)
Table 37. China Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share (2018-2023)
Table 47. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product and Services
Table 64. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Kangtai Basic Information, Manufacturing Base and Competitors
Table 68. Kangtai Major Business
Table 69. Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product and Services
Table 70. Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Kangtai Recent Developments/Updates
Table 72. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 73. Walvax Biotechnology Major Business
Table 74. Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product and Services
Table 75. Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 76. Global Key Players of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Upstream (Raw Materials)
Table 77. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Typical Customers
Table 78. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Typical Distributors
List of Figure
Figure 1. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Picture
Figure 2. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029) & (K Units)
Figure 5. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029) & (K Units)
Figure 10. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029) & (K Units)
Figure 12. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Markets in 2022
Figure 26. United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share 2022
Figure 32. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share by Type in 2022
Figure 34. Vials
Figure 35. Pre-filled
Figure 36. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share by Type (2018-2029)
Figure 37. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share by Type (2018-2029)
Figure 38. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. CDC
Figure 44. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share by Application (2018-2029)
Figure 45. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share by Application (2018-2029)
Figure 46. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Industry Chain
Figure 48. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Procurement Model
Figure 49. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Model
Figure 50. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Table 1. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share by Region (2018-2023)
Table 9. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share by Region (2024-2029)
Table 10. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Major Market Trends
Table 13. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Producers in 2022
Table 18. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Producers in 2022
Table 20. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Company Evaluation Quadrant
Table 22. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Site of Key Manufacturer
Table 24. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market: Company Product Type Footprint
Table 25. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market: Company Product Application Footprint
Table 26. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Competitive Factors
Table 27. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine New Entrant and Capacity Expansion Plans
Table 28. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share (2018-2023)
Table 37. China Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share (2018-2023)
Table 47. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product and Services
Table 64. Pfizer 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Kangtai Basic Information, Manufacturing Base and Competitors
Table 68. Kangtai Major Business
Table 69. Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product and Services
Table 70. Kangtai 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Kangtai Recent Developments/Updates
Table 72. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 73. Walvax Biotechnology Major Business
Table 74. Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Product and Services
Table 75. Walvax Biotechnology 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 76. Global Key Players of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Upstream (Raw Materials)
Table 77. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Typical Customers
Table 78. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Typical Distributors
List of Figure
Figure 1. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Picture
Figure 2. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029) & (K Units)
Figure 5. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029) & (K Units)
Figure 10. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production (2018-2029) & (K Units)
Figure 12. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Markets in 2022
Figure 26. United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share 2022
Figure 32. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share by Type in 2022
Figure 34. Vials
Figure 35. Pre-filled
Figure 36. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share by Type (2018-2029)
Figure 37. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share by Type (2018-2029)
Figure 38. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. CDC
Figure 44. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Market Share by Application (2018-2029)
Figure 45. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Production Value Market Share by Application (2018-2029)
Figure 46. World 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 47. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Industry Chain
Figure 48. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Procurement Model
Figure 49. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Model
Figure 50. 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
